clopidogrel has been researched along with Colorectal Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CW; Chen, HM; Ho, PH; Hsiao, HC; Kuo, CJ; Lim, SN; Lin, WR; Yeh, CT | 1 |
| Bastiaannet, E; Frouws, MA; Lemmens, VE; Liefers, GJ; Portielje, JEA; Rademaker, E; Van de Velde, CJH; van Herk-Sukel, MPP | 1 |
| Doan, G; Kaltenbach, T; Lin, D; McQuaid, K; Mou, S; Pham, C; Rouse, RV; Shergill, AK; Soetikno, RM; Somsouk, M | 1 |
| Baiwir, D; Bouznad, N; Delierneux, C; Delvenne, P; Dibato Epoh, J; Lancellotti, P; Mazzucchelli, G; Oury, C; Rahmouni, S; Servais, L; Wéra, O | 1 |
| de Abajo, FJ; García-Rodríguez, LA; Gil, M; Montoya, H; Rodríguez-Martín, S; Rodríguez-Miguel, A | 1 |
| Chan, AT; Jovani, M | 1 |
| Cardwell, CR; Hicks, BM; Hughes, C; Murray, LJ | 1 |
7 other study(ies) available for clopidogrel and Colorectal Neoplasms
| Article | Year |
|---|---|
Anticoagulant drugs with or without proton pump inhibitor and colorectal cancer risk: a population-based, case-control study.
Topics: Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Colorectal Neoplasms; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies | 2022 |
The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Colorectal Neoplasms; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netherlands; Platelet Aggregation Inhibitors; Survival Analysis; Ticlopidine | 2017 |
Risk factors for postpolypectomy bleeding in patients receiving anticoagulation or antiplatelet medications.
Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Female; Gastrointestinal Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Thromboembolism; Ticlopidine; Time Factors; Warfarin | 2018 |
Platelets contribute to the initiation of colitis-associated cancer by promoting immunosuppression.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Blood Platelets; CD8-Positive T-Lymphocytes; Cells, Cultured; Clopidogrel; Colitis; Colon; Colorectal Neoplasms; Disease Models, Animal; Immune Tolerance; Lymphocytes, Tumor-Infiltrating; Male; Mice, Inbred C57BL; Myeloid Cells; Phenotype; Platelet Activation; Platelet Aggregation Inhibitors; Serum Amyloid A Protein; Tumor Escape | 2018 |
Clopidogrel and Low-Dose Aspirin, Alone or Together, Reduce Risk of Colorectal Cancer.
Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Clopidogrel; Colorectal Neoplasms; Dual Anti-Platelet Therapy; Female; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Factors; Risk Reduction Behavior; Salicylates; Spain | 2019 |
Do Aspirin and Clopidogrel Follow the Same Road Toward Prevention of Colorectal Cancer?
Topics: Aspirin; Clopidogrel; Colonic Neoplasms; Colorectal Neoplasms; Humans; Platelet Aggregation Inhibitors | 2019 |
Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Cause of Death; Clopidogrel; Colorectal Neoplasms; Databases, Factual; Drug Prescriptions; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Patient Safety; Pharmacoepidemiology; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; United Kingdom | 2015 |